Isomorphic Labs Raises $600 million Series A

Isomorphic Labs raised $600M in Series A financing with participation from Alphabet, Various Life Science VCs. Google DeepMind spinout — AlphaFold drug discovery. The new capital is framed around Build drug discovery pipeline with pharma partners.

What it does

Google DeepMind spinout — AlphaFold drug discovery. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.

Traction

AlphaFold 3 predicts all molecular interactions — wins Nobel Prize. Management framed the new capital around Build drug discovery pipeline with pharma partners.

Trend impact

MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.

Funding history

• Recent · Series A · $600 million · Various Institutional, alongside Alphabet, Various Life Science VCs